We also show that the two antihormones, 4-hydroxytamoxifen (OHT, a partial ER agonist) and ICI 164,364 (a pure antagonist) do not impair HEGO dimerization and DNA binding in vitro. Exposure of HEGO to elevated temperature (37 C) in vitro results in a much faster reduction of its binding capacity to an ERE in the absence of ligand or in the presence of ICI 164,364 than in the presence of either E2 or OHT. The Gly to Val mutation at amino acid 400 present in the human ER that we initially cloned (HEO), is responsible for an even faster heat inactivation of unliganded receptor compared with HEGO and largely accounts for the previously observed in vitro ligand-dependent DNA binding of ER. We also show that, as previously observed for OHT, ICI 164,364 does not prevent ER binding to an ERE in viva, even though ICI 164,364 acts as a pure antagonist for transcriptional activation by ER. We discuss these results in the context of a ligand-dependent interaction between the C-terminal region E, which contains the ligand-binding domain, and the N-terminal A/B region, which contains the activation function AF-1. (Molecular Endocrinology 9: 579-591, 1995)
INTRODUCTION
Steroid hormones regulate initiation of transcription of target genes by binding to nuclear receptors that interact with specific DNA sequences called response elements. Cloning of the cDNAs encoding receptors for estrogens, progestins, androgens, glucocorticoids, mineralocorticoids, and ecdysteroids has revealed that these receptors belong to a gene superfamily that includes vitamin D,, retinoic acid and thyroid hormone receptors, peroxisome proliferator-activated receptors, developmental regulatory proteins in Drosophila, and several vertebrate orphan receptors whose possible ligands are as yet unknown (l-7).
Nuclear receptors can be divided into six regions (A to F) according to the degree of amino acid sequence conservation (2, 8) . The 66-68 amino acid-long core of region C is highly conserved throughout the family and is responsible for response element-specific DNA binding (Refs. 9-21 and references therein). The length and sequence of the N-terminal A/!3 region of the various nuclear receptors is variable and, in a number of cases, a transcriptional activation function (AF-1, previously called TAF-1) has been mapped to this region (10, (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) . Region E, which is also well conserved, contains the ligand-binding domain and a hormone-inducible transcriptional activation function (AF-2, previously called TAF-2) (Refs. 10, (23) (24) (25) (27) (28) (29) (32) (33) (34) (35) . In the case of the estrogen receptor (ER) it has been shown that region E is also involved in nuclear localization (Refs. 36 and 37 and references therein), association with the heat shock protein hsp90 in vitro (38) and dimerization of the receptor (39, 40) . A weaker dimerization domain is also associated with region C of the ER (17, 18, 39) . Region D, which is much less well conserved, also contributes to formation of the ER-hsp90 complex in vitro (see Ref. 38 for references) and to nuclear localization (37).
The mechanism by which ligands control the function of nuclear receptors remains to be clarified. The classical model for steroid hormone action proposes that binding of the ligand by the receptor induces structural changes leading to nuclear localization, DNA binding, and activation or repression of transcription. In the case of ER, which is nuclear even in the absence of estrogen (E2) (37), E, is thought to induce dissociation of the complex composed of ER and hsp90, allowing ER to bind DNA. Salt treatment has also been reported to induce binding of unliganded ER to DNA (41). In vitro functional analyses performed with the human ER (hER) initially cloned by us (HE0 cDNA) (42, 43) and expressed in either HeLa cells (39, 44) , Xenopus oocytes (45) or yeast (46), or produced by in vitro transcription/translation (47), have shown that binding of ER to an estrogen response element (ERE) was hormone-dependent, and also that E, induced the formation of receptor dimers (39). However, DNA binding of HE0 produced in Sf9 cells (baculovirus system) was reported to be hormone-dependent in the presence, but not in the absence, of Mg++ and that this dependency was more pronounced at higher temperatures (48). We have previously reported that HE0 contains an artifactual point mutation resulting in the substitution of a glycine at position 400 by a valine (Gly400 + Val; see Ref. 49 ) and shown that this point mutation decreased the hormone binding at 25 C, but not at 4 C. On the other hand, it has been reported that the wild type hER, HEGO (also designated hER,,,,,,) produced either by in vitro transcription/translation or in transfected COS-1 cells, binds strongly to an ERE even in the absence of hormone (42, 50). Hormoneindependent formation of ER-ERE complexes has also been observed with extracts (51) and purified receptor (52, 53) from calf uterus, rat uterine extracts (54, 55), mouse uterine extracts (56, 57) and with mouse ER produced either by in vitro transcription/translation (26, 58), in transfected COS-1 cells (58, 59), or in Sf9 cells infected with a recombinant baculovirus (40, 58). In contrast, ligand-inducible DNA binding, using HEGO produced by in vitro transcription/translation or in Sf9 cells, has also been reported (60). In vivo hormoneindependent association of hER with MCF-7 cell chromatin has been observed (61), thus suggesting that E, may not be required for ER binding to the ERE, but only to convert the receptor bound to DNA into a transcriptionally active form. Ligand-dependent and ligand-independent ERE binding has also been reported for hER and Xenopus ER, respectively, by using a promoter interference assay (62, 63). However, in yeast, chromatin structure studies of an estrogen-responsive promoter have indicated that hER DNA binding is ligand-dependent in viva (64), and it was shown that hormone may be required to promote DNA binding at low, but not at high, receptor concentration (65). Furthermore, in vivo genomic footprinting experiments have indicated that occupation of the ERE present in the apoVLDLll promoter region is hormone-dependent (66) thus suggesting that the hormone is required for the ER to bind to the ERE.
The nonsteroidal antiestrogen OHT has been shown to affect hER activity by interfering with the transcriptional activation function AF-2 located in the hormonebinding domain, rather than by inhibiting DNA binding (23, 28) The above discrepancies in the effect of E, and ICI on the ability of the ER to bind to an ERE may reflect species differences in ERs or merely differences in the methods used to overproduce and extract ER and in testing DNA binding. We therefore decided to systematically study the in vitro ERE binding characteristics of wild type hER (HEGO) and of the mutant form (HEO), produced and extracted in various ways. We show here that the binding capacity of wild type hER to an ERE in vitro is more sensitive to elevated temperature in the absence of ligand than in the presence of either E, or OHT. Moreover, the pure antagonist ICI 164,384 does not protect the receptor from rapidly loosing its ability to bind DNA at elevated temperatures.
Interestingly, the hER,,,,,, mutant (HEO) appears to be much more temperature-sensitive than HEGO, which accounts for the differences in DNA binding properties between the wild type and this mutant hER. We also report that transformation of the receptor by high salt (HS), E, and/or elevated temperature is not required for efficient binding of wild type hER to an ERE in vitro. (Fig. 1 ). In agreement with our previous results and those of others (see Introduction), HE0 bound DNA in the presence, but not in the absence, of E,. A retarded complex was also seen in the presence of OHT, but it migrated more slowly than the E2-ER-ERE complex. DNA binding by HE0 was also observed in the presence of ICI, but at much lower level than with either E, or OHT. The ICI-ER-ERE complex migrated at a position intermediate between those of E, and OHT complexes. Similar binding was observed irrespective of the expression system used ( -12) , or HEG19 produced in transiently transfected COS-1 cells(C) extracted in HS buffer. The preincubation step was performed at 4 C in the presence of either E, (100 nM), OHT (100 nM), or ICI (100 nM) or in the absence of ligand (-, ethanol vehicle alone, 0.1% final concentration) as indicated. The incubation step with the radiolabeled ERE was performed at 37 C for 20 min. aa corresponds to ER homodimers complexed to the ERE and bb and ab to homo-and heterodimeric forms of proteolysed receptors complexed to the ERE. D, Schematic representation of HEO, HEGO, and HEG19. l-4 with lanes 5-8 and lanes 9-l 2). Note the presence of two additional complexes with HE0 produced in RRL and COS-1 cells. The upper complex corresponds to a homodimer of ER complexed to the ERE (aa, Fig. 1 ), whereas the other complexes probably correspond to homo-and heterodimeric forms of Nterminally proteolysed receptors (bb and ab respectively, in Fig. 1 
Effect of Temperature on in Vitro ERE Binding by hER
The effect of temperature on ER DNA binding was investigated using in vitro untreated or ligand-treated HS extracts from COS-1 cell transfected with HEGO. After a preincubation at 4 C or at 37 C for 15 min, radiolabeled ERE was added for 15 min at 37 C, and the complexes formed were analyzed by EMSA ( Fig.  2A ). In the presence of E, or OHT, preincubation at 4 C or 37 C had little effect on DNA binding ( Fig. 2A , compare lanes 3 and 4, and lanes 5 and 6), whereas in the absence of ligand, or in the presence of ICI, incubation at 37 C resulted in greatly reduced DNA binding (compare lanes 1 and 2 and lanes 7 and 8). Western blot analysis showed that the reduced DNA binding in the latter cases was not due to degradation of HEGO during incubation (Fig. 26) . Similar results were obtained with HEGO produced in rabbit reticulocyte lysate (data not shown). When HE0 was used in this assay the results were similar to those shown in Fig. 1 , whether the preincubation was carried out at 4 C or at 37 C (data not shown).
The above results suggest that hER is inactivated in some way by preincubation at 37 C in the absence of ligand and in the presence of the antagonist ICI. To confirm this, untreated or ligand-treated HEGO-containing COS-1 cell HS extracts were preincubated for varying lengths of time at either 4 C or 37 C, at which point labeled ERE was added, and the reactions were further incubated at 37 C for 20 min. Preincubation at 4 C had no effect on DNA binding by HEGO (data not were preincubated (30 min) in the absence of hormone (lanes l-2), in the presence of 100 nM E, (lanes 3-4), 100 nM OHT (lanes 5-s), or 100 nM ICI (lanes 7-8) at either 4 C or 37 C (as indicated).
The incubation step with the radiolabeled ERE was at 37 C for 30 min. B, Western blot analysis of the extracts treated as indicated above using anti-ER F3 monoclonal antibody (Materials and Methods).
shown). At 37 C HEGO retained its capacity to bind to an ERE even after a long preincubation at 37 C in the presence of either E, or OHT, whereas in the absence of hormone or in the presence of ICI only about 30% of the complexes were formed after 15 min of incubation at 37 C (Fig. 3A) . This loss of DNA binding ability by HEGO in the absence of E, was irreversible, since addition of E, after the preincubation step at 37 C did not increase DNA binding (data not shown).
To examine the effect of temperature on specific complex formation, the preincubation step was performed at 4 C, and the DNA-binding step was performed at either 37 C or at 4 C. At 37 C, maximum binding was observed after a 30-min incubation with the ERE in the presence of E, or OHT. However, binding was maximal after 5 min in the absence of hormone or in the presence of ICI and, at best, represented less than 40% of the maximal binding observed in the presence of E, (Fig. 38) . By contrast, when the binding reactions were performed at 4 C, complex formation was similar in the absence or presence of ligand (Fig. 3C ). The presence of 5-10 mM Mg++ during the reactions did not modify the hormone independence of the binding of HEGO to the ERE (data not shown). Although the time taken for maximal binding to be achieved was much greater, more complex was formed at 4 C than at 37 C using the same amount of HEGO-containing extracts (compare panels B and C of Fig. 3 ). The reduction of EREbinding capacity by heat treatment in the absence of hormone was even more pronounced for HE0 than for HEGO. Figure 4A represents the amount of ERE-hER complexes formed with untreated or hormone-treated HE0 and HEGO-containing COS-1 cell extracts after preincubation for 15 min to 1 h at 37 C, followed by a 2-h DNA-binding step at 4 C before EMSA analysis. Preincubation at 37 C had no effect on DNA binding by E,-treated HE0 and HEGO. However, in the absence of ligand, a 15min preincubation at 37 C resulted in a 85% reduction of the DNA-binding capacity of HEO, and only in a 60% reduction for HEGO; after a 30-min preincubation at 37 C, complex formation with HE0 was almost totally abolished, whereas it was reduced by 75% in the case of HEGO. In contrast, by performing the preincubation and incubation reactions at 4 C, DNA binding was hormone-independent for HEO, as well as for HEGO (Fig. 4B and data not shown).
Effect of Ionic Strength on Binding of ERE by hER in Vitro
The binding of hER to DNA may be affected by pretreatment with salt (see Introduction).
To investigate whether an HS treatment of the receptor is required for DNA binding, HEGO-transfected COS-1 cells were extracted in a low salt (LS) buffer (50 mM KCI). Salt was added to aliquots of these extracts to a final concentration of 400 mM KCI for 30 min at 4 C. Salt-treated and untreated extracts were then preincubated in the absence or presence of ligands in EMSA buffer (80 mM KCI final concentration) at 4 C for 30 min before incubation with labeled ERE (2 h at 4 C for Fig. 5A or various times for Fig. 5B ). HEGO extracted in LS buffer, bound DNA in the absence of hormone, irrespective of an additional HS treatment (Fig. 5A , compare lanes 1 and 5). Furthermore, the presence of ligands (E2, OHT, ICI) did not significantly affect the amount of complex formed (compare lanes 2-4 to lane 1, and lanes 6-8 to lane 5, in Fig. 5A ) or the kinetics of its formation (see Fig. 58 ).
In fact, HEGO, whether extracted in HS or LS buffer, bound DNA in the absence of hormone, provided that the final salt concentration in the binding reaction was at least 50 mM. Optimum DNA binding occurs at 100 mM KCI, even though the receptor was present as a 9s form at this salt concentration (data not shown). These results indicate that salt transformation of the receptor is not required for ERE binding. or presence of 100 nM 4 6, as indicated) followed by a 30-min incubation at 4 C in the presence of 100 nM 4. The incubation step with the radiolabeled ERE was performed at 4 C for 2 h. After electrophoresis, the specitic retarded complex and unbound ERE were excised and the radioactii counted. The amount of complex formed in the presence of 4 without preincubation at 37 C is taken as 100%. B, EMSA was performed with extracts of CDS-1 cell transfected with HEGO, HEO, or pSG1 (as indicated) (extraction in 0.4 M KCI) after preincubation for 2 h at 4 C in the absence (lanes 1-3) or in the presence (lanes 4-6) of 100 nM E2. The incubation steo with the radiolabeled ERE was at 4 C for 2 h.
ER Binds in vitro to DNA as a Dimer in the Absence and Presence of E,, OHT, or ICI
We analyzed the dimeric status of hER bound in vitro to an ERE using extracts of transfected COS-1 cells expressing HEGO and/or HEG19, a mutant of HEGO from which the N-terminal region A/B has been deleted (see Fig. 1 D and Ref. 28) . Hormones or antihormones were added to the cell culture medium for 1 h as indicated (Fig. 6A ). The HEG19 complex (Fig. 6A , lanes 9-12) migrated faster than that formed with HEGO (Fig. 6A, lanes l-4) , and the amount of complex formed correlated with the amount of receptor present in the extracts as determined by Western blot analysis (data not shown). When HEGO and HEG19 were coexpressed in COS-1 cells, an additional complex with an intermediate migration was observed, corresponding to the binding of HEGO/HEGlS heterodimers. The presence of ligands did not significantly affect the amount of heterodimeric complexes formed (Fig. 6A , lanes 5-8, and data not shown). These results demonstrate that the ER binds DNA as a dimer, irrespective of the absence or presence of the various ligands tested. We also tested whether the addition of the ligands in vitro had an influence on the formation of heterodimeric complexes when cell extracts containing unliganded HEGO or HEG19 were mixed in vitro. In all four cases, similar amount of heterodimeric complexes were formed (Fig. 6B, lanes l-4) . That ICI did not prevent the formation of dimeric complexes in vitro was further supported by the result obtained at a different HEGO/HEGlS ratio (Fig. 6B, lanes 5-10) . Similar results were obtained with HEGO produced in Sf9 insect cells using a baculovirus expression system. HEGO bound to DNA both in the presence or in the absence of E, or ICI. By mixing HEGO produced in 39 cells with HEG19 produced in COS-1 cells, two strong complexes corresponding to homodimers were seen, whereas only a faint heterodimeric complex could be detected (lanes 4 and 7, Fig. 6C ). Addition of E, or ICI to the extracts, before or after mixing HEGO with HEG19, did not affect the formation of het- 8) . B, Extracts were preincubated for 30 min at 4 C in the absence of ligand or in the presence of 100 nM E,, 100 nM OHT, or 100 nM ICI (as indicated).
The EMSA reaction was then performed at 80 mM KCI, and at 4 C for various times (as indicated). After electrophoresis, the specific retarded complex and unbound ERE were excised and the radioactivity counted. Taken all together, these results indicate that the ER binds to DNA in vitro as a dimer irrespective of the absence or presence of E,, OHT, or ICI. Note also that less heterodimeric complexes were formed when HEGO and HEGl9 were mixed in vitro when compared with complexes formed with extracts containing coexpressed HEGO and HEGl9 (compare Fig. 68 , lanes l-4 to Fig. 6A , lanes 5-8; see also Fig. 6C ), indicating that some dimers preexisted in the extracts before binding to the ERE.
The ER Binds to DNA in the Presence of ICI in Vivo
The above results show that hER can bind an ERE in the presence of ICI in vitro. We therefore investigated whether hER could also bind DNA in the presence of ICI in vivo. We first constructed a chimeric receptor containing an ICI-insensitive heterologous transcriptional activation function designated VP1 6-HEGl9, in which the acidic transcriptional activating domain of VP16 is associated with the ER DNA-binding and ligand-binding domains. The activity of this chimeric receptor was tested in HeLa cells using the ERE-TATA-CAT reporter plasmid (Fig. 7A) was a strong activator (Fig. 7B) , thus indicating that it was bound to DNA. Although the above results suggest that the ER can bind to an ERE in the presence of ICI in viva, it could not be excluded that in the wild type receptor, the presence of the A/B region may result in a different structure for which ICI could prevent DNA binding. To demonstrate that HEGO can indeed bind DNA in the presence of ICI, we constructed a chimeric luciferase reporter gene containing a 17 mer response element (17M) for the yeast transactivator GAL4, followed by a response element for the ER (ERE), which was itself located upstream of the 8-globin promoter region (17M/ERE-G-LUC, see Fig. 8A ). This reporter plasmid was activated by HEGO in the presence of E,, and some transcriptional activity was also observed in the absence of E, addition (Fig. 8B) . As previously reported, this activity was suppressed upon addition of ICI or OHT (Fig. 8B and data not shown; see Fiefs. 28 and 49) . No induction of transcriptional activity by HEGO was observed using the 17M/GRE-G-CAT reporter plasmid in which the ERE has been replaced by a glucocorticoid response element to which ER cannot bind (Fig. 8, A and B, and data not shown). Both reporters were constitutively activated by the chimeric activator GAL4-VP1 6 bound to the 17M site ( Fig. 8C; with HEGO and/or GAL4-VPl6, were grown in the absence of hormone (charcoalstripped medium) or in the presence of E, or ICI for 24 h. Luciferase and chloramphenicol acetyltransferase (CAT) activities in various extracts were determined (Fig. 8C) . Neither E, nor ICI significantly affected luciferase or CAT expression in GAL-VP1 6-transfected cells. On the other hand, when HEGO was cotransfected, the expression of the 17M/ERE-G-LUC reporter was 3-fold decreased in the presence of ICI, whereas it was 5fold increased in the At the beginning of the reaction 2.5 pg of extracts containing HEGO or HEGl9 were mixed (lanes l-4). Similarly, 6 pg and 1.5 pg of extracts containing HEGO and HEGl9, respectively, were mixed (lanes 7 and 8). Lanes 5 and 6 contained HEGO-transfected cell extracts alone (6 pg) and lanes 9 and 10 contained HEG19-transfected cell extracts alone (1.5 pg). Incubation with radiolabeled ERE was carried out for 2 h at 4 C. C, Sf9 cells expressing HEGO (a gift of L. Tora and H. Gronemeyer) and COS-1 cells expressing HEG19 were extracted in HS DNA-binding buffer. The first preincubation step 1 corresponded to a 30-min incubation at 4 C in EMSA buffer (80 mM KCI) in the absence of ligand (lanes 1,4, and 7-l 0) or the presence of 100 nM E, (lanes 2, 5, and 11) or 100 nM ICI (lanes 3, 6, and 12). HEGO and HEGl9 were mixed in lanes 4-9 at the beginning of the reaction, whereas lanes l-3 contained HEGO and lanes 1 O-l 2 contained HEGl9 alone.
Step 2 corresponds to a further 30-min incubation at 4 C, where E, and ICI (100 nM) were added to the samples corresponding to lanes 8 and 9, respectively. Incubation with radiolabeled ERE was carried out for 2 h at 4 C. HEGO and HEG19 homodimers and HEGO-HEG19 heterodimers complexed to the ERE are indicated in panels A-C by xx, xy, and yy, respectively. Note that in the absence of ligand, the presence of HEGO did not result in any inhibition of transcriptional activation by GAL-VP1 6. This may indicate that the ER cannot bind DNA in the absence of ligand in vivo. Alternatively, this lack of inhibition could result from ligand-independent transcriptional activity of HEGO (see above, Fig. 8B ), which may be due to the presence of residual estradiol in the charcoal-stripped cell culture medium.
DISCUSSION
The Wild Type ER (HEGO) Binds an ERE in Vifro as a Dimer Irrespective of the Presence or Absence of E,, OHT, or ICI 164, 384 We have studied here the DNA binding and dimerization characteristics of the hER in the absence or presence of estradiol and of two antiestrogens, OHT and ICI. We show that the cloned, wild type receptor hER g,y400 (HEGO), produced in several systems (in vitro transcription/translation, transiently transfected COS-1 cells, recombinant baculovirus-infected Sf9 cells, or transformed yeast cells) binds to the Xenopus viteilogenin A2 gene palindromic ERE in vitro in the absence of any ligand. These results are in agreement with those reported previously using the rat, mouse, calf, and human ER (26, 40, 47, (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) . Furthermore, in the absence of any ligand, more heterodimeric complexes are formed with the ERE when the full-length ER, HEGO, and the A/B-truncated mutant, HEGl9, are coexpressed in COS-1 cells, than upon mixing in vitro extracts containing HEGO expressed either in COS-1 cells or in Sf9 ceils, with extracts containing HEGl9 expressed in COS-1 cells. These observations, which suggest that ER dimers preexist in cell extracts in the absence of hormones, are in keeping with the previous study of Skafar (70) (1 pg) together with either the parental vector pSG5 (50 ng, lanes l-4), HEG19 (50 ng, lanes 5-Q or VP16-HEG19 (50 ng, lanes 9-l 2). Cell cultures were maintained in the absence (-) or presence (+) of E2 (10 nM), OHT (100 nM), or ICI (100 nM) as indicated.
CAT activity was assayed after normalization for 6-galactosidase activity from the reference plasmid pCHll0
(Materials and Methods).
even though under these latter conditions the receptor existed in a 9s form in the ERE-binding assay mixture (data not shown). Note also that we have not detected any significant differences in the affinity of HEGO for DNA and in the presence or absence of E, (data not shown; see also Fiefs. 52, 54, and 56).
Although neither E, nor OHT appears to affect the dimerization properties of HEGO in vitro, our results show clearly that E,, as well as OHT, prevents heat inactivation of the receptor, and that the in vitro DNA-binding characteristics of HEGO are similar in the presence of E2 or OHT. Thus, even though the rate at which HEGO binds DNA at 4 C is slower than at 37 C, the maximal amount of complex eventually formed is higher at 4 C than at 37 C, irrespective of the presence of the ligand. Note in this respect that the DNA-binding capacity of the unligandad receptor is irreversibly lost at elevated temperature. It is also noteworthy that even at 4 C, the kinetics of DNA binding is the same in the presence or absence of ligand, which supports the conclusion that ERE binding by HEGO in vitro does not require transformation of the receptor into a 4-5 S form. Since we have previously shown that a highly positively charged region situated at the C-terminal extremity of the DNA-binding domain of hER is implicated in hsp90 association in vitro (38), there is a possibility that hsp90 could be displaced by the ERE during the binding reaction. This is unlikely, since the kinetics of DNA binding at 4 C were identical over a large range of ERE concentrations (data not shown). We also show conclusively here that wild type hER (HEGO) [whether it is produced in transfected COS-1 cells, by in vitro synthesis, in yeast (see Fig. l) , or in insect cells using recombinant baculovirus (see Fig. SC )], as well as chicken ER produced in COS-1 cells or in insect cells (data not shown), efficiently binds an ERE when ICI is added to the receptor preparation or when the transfected COS-1 cells are exposed to ICI. DNA binding in vitro in the presence of ICI was previously reported for the purified calf ER (52, 53), and with HEO-containing HeLa extract (44). Furthermore, ICI does not reduce the formation of heterodimeric complexes in cells cotransfected with HEGO and HEGl9, or that of dimers obtained upon mixing extracts containing HEGO and HEGl9 (see Fig. 6 ) demonstrating that this antagonist does not inhibit dimerization.
These results are in contrast with those of Parker's group (40, 58, 59 ) who found that ICI prevents dimerization and DNA binding of the mouse ER. The reason for this discrepancy is unknown but cannot be due to the lack of binding of ICI to our receptor preparation, since the migration of the ICI-HEGO-ERE complex was different from that of unligandad HEGO, as well as from the complexes formed in the presence of E, or OHT. These findings suggest that the structure of the ER is differentially altered upon binding of either E,, OHT, or ICI. Interestingly, these conformational changes appear to affect the stability of the ER, since ICI is much less efficient than either E, or OHT at protecting the ER against heat denaturation.
The Glycine to Valine Point Mutation at Amino Acid Position 400 of hER (HEO) Affects Its DNABinding Capacity at Elevated Temperature In contrast to wild-type hER (HEGO), and in agreement with previous reports (39, 44, 46 ) the binding to DNA of the originally cloned hER [HEO, which contains an artifactual Gly --, Val mutation (49)], is E,-dependent when carried out at 20 C-37 C, irrespective of the system used to produce it. The present data show clearly that this dependance can be ascribed to a faster heat inactivation of unliganded HEO, when compared with unliganded HEGO. In contrast, when the preincubation and ERE-binding reactions were performed at 4 C, the DNA binding of HE0 was hormoneindependent.
Presumably the Gly + Val mutation, which is known to affect ligand binding at elevated temperature (49) also alters the structure of the dimerization surface which overlaps the ligand-binding domain. Consequently, dimerization and therefore DNA binding would be affected at elevated temperatures, and the ligand dependency of DNA binding would We have previously shown that while E, can induce the activity of the two activation functions (AF-1 and AF-2) of hER, OHT selectively blocks the activity of AF-2, thus accounting for its cell-and promoter-specific mixed agonistic/antagonistic effect (Refs. 25 and 28 and references therein). In principle, the full antagonistic action of ICI in viva (Ref. 28 and references therein) could be due either to an inhibition of binding of the ER to DNA or to an inhibitory effect on both AF-1 and AF-2.
Two different approaches were used here to demonstrate that ICI does not inhibit the binding of HEGO to DNA in vivo. We first showed that a chimeric receptor (VP1 6-HEGIg), containing the VP1 6 acidic activating domain instead of the N-terminal activation function AF-1, stimulates transcription in the presence of hER. It appears therefore, that the transcriptional inactivity of ER in the presence of ICI is not due to an inhibition of DNA binding but to a complete block of the activity of both AF-1 and AF-2.
Using the same assay system, no inhibition of transcription was observed with the unliganded receptor. However, the possible presence of residual E, in the E,-stripped cell culture medium, does not allow us to conclude unequivocably whether the receptor can or cannot bind DNA in vivo in the absence of ligand. Similar experiments performed in yeast have suggested that ER DNA binding is hormone-dependent at low, but not high, concentrations of receptor (68), whereas in animal cells both ligand-dependent and ligand-independent ERE binding has been reported with ER from different species (62, 63) . Analysis of the chromatin structure at an ERE-containing reporter gene in yeast has indicated that hER requires estradiol to bind DNA (64). Thus, whether the unliganded ER can bind to an ERE in vivo in the absence of estrogen remains to be clarified.
Conclusion
Our present results demonstrate that the ER can bind to an ERE in vitro in the absence of any agonistic or antagonistic ligand. The previously reported requirement of estrogen (39) with the initially cloned ER mutant HE0 (see Ref. 49 ) was clearly reflecting a protective effect of estrogen against heat denaturation of ER. In this respect, OHT appears to be as efficient as estradiol, whereas the pure antagonist ICI is much less effective, which may, at least in part, account for the decrease in ER levels observed in ICI-treated cells (59, 69) . We have previously reported that the ER can bind to an ERE in the presence of OHT, which prevents activation of transcription by the activation function AF-2, while AF-1 can still transactivate in a promoterand cell context-dependent manner (28, 73) thus accounting for the mixed agonisticlantagonistic effect of OHT. Interestingly, we show here that ICI does not prevent ER binding to an ERE, even though it is known to act as a pure transcriptional antagonist (Refs. 28 and 74, and references therein). It is noteworthy that the chimeric receptor VPlG-HEG19, in which the ER N-terminal A/B region has been replaced by the acidic activator VP1 6, does transactivate in the presence of both OHT and ICI. Therefore, binding of different ligands to the ER C-terminal ligand-binding domain affects the function of the N-terminal region in a specific manner, which is dependent on both the ligand and the N-terminal-activating domain. The function of AF-1 is prevented in the case of ICI, but not of OHT, while both OHT and ICI allow transactivation by the VP1 6 activating domain of VP1 6-HEGI 9. Clearly there is some cross-talk between the otherwise seemingly independent N-and Gel Retardation/Shift Assay (EMSA)
Gel retardation assays (20 ~1) contained l-10 pg extract, 2.5 pg poly(dl-dC), and 50,000 cpm of 5'-[32P]-end-labeled double-stranded ERE (5'-TCGAGCAAAGTCAGGTCACAGT-GACCTGATCAAT-3') in 10 mM Tris-HCI, pH 7.5, 0.5 mM EDTA, 0.5 mM DTT, 80 mM KCI, 5% glycerol (vol/vol), 0.5 mM phenylmethylsulfonylfluoride, and 1.25 mg/ml of leupeptin, pepstatin, chymostatin, antipain, and aprotinine. Mixtures were preincubated for 30 min on ice in the presence or absence of hormones before addition of the ERE (preincubation step), and then for 20 min at 37 C (incubation step) for standard experiments. Different preincubation and incubation times and temperatures were used as described in the figure legends.
Receptor-DNA complexes were separated on preelectrophoresed 5% polyactylamide [30% acrylamide, 1% bisacrylamide containing 44.5 mM Tris-borate, 44.5 nM boric acid, 5 mM EDTA (0.5 x TBE)]. Gels were run in 0.5 x TBE at 150 V and dried before autoradiography.
For quantitative studies, the bands corresponding to the specific retarded complex of hER-ERE and to the unbound ERE were excised, and the radioactivity was determined by liquid scintillation counting.
Western Blot Analysis 7.
Western blot analysis was performed as described (46) 
